MedDataX Logo

Telenhealth and Adherence to Stains

NCT ID: NCT05872919

Last Updated: 2024-12-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-07-15

Study Completion Date

2024-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the effect of telehealth through short messaging services (SMSs) on adherence to statins in patients with diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Telehealth , Lipid Lowering Medication Adherence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Eligible patients will be offered to participate. Willing patients will be randomly assigned to one of two groups: Two arms study design: first arm (control group)won't receive intervention while the second arm (intervention group) will receive telenursing intervention through SMS; Is a text messages will be sent to the intervention group comprised of a reminder on when, how to take lipid lowering medication, benefits, and adverse effect of not taken the drug as prescribed for three months duration. SMS (Short Messaging Service) will be sent three times per week in the first six weeks and twice per week in the second six weeks.
Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Caregivers Outcome Assessors
MA will provide randomization AD will assess participant at baseline and follow-up EH will deliver the intervention.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

will not receive the intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Study group

will receive the intervention

Group Type EXPERIMENTAL

SMS reminder massages about adherence

Intervention Type OTHER

SMS three-times per week in the first six weeks and twice per week in the second six weeks reminding the patient about adherence to prescribed medication

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SMS reminder massages about adherence

SMS three-times per week in the first six weeks and twice per week in the second six weeks reminding the patient about adherence to prescribed medication

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (≥18 years)
* Both sexes
* Type 1 and 2 diabetes
* Had a prescription of lipid lowering medication with a minimum duration of two weeks
* Have an active contact phone number that can receive text messages
* Able to read SMS text messages (patient, or family member)

Exclusion Criteria

* Communication impairment
* Taking any psychotropic medications
* Familial hypercholesterolemia
* Already established coronary heart disease
* not on lipid lowering medication
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amna A. Desouky, MD

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Nursing

Asyut, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Adherence for medication

Identifier Type: -

Identifier Source: org_study_id